DCM
GHDX

Decade Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

Decade Capital Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$8.87M Buy
+419,274
New +$10.8M 1.91% 17

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decade Capital Management's GHDX Position: Q3 2015 in Review

Decade Capital Management opened a new position in Genomic Health, Inc. (GHDX) in Q3 2015: 419,274 shares worth $8.87M. The stake represents 1.91% of the portfolio and ranks #17 among its holdings.

117 funds tracked by Wall St. Rank hold GHDX as of Q3 2015.

  • Decade Capital Management held 419,274 shares of Genomic Health, Inc. worth $8.87M as of Q3 2015.
  • Genomic Health, Inc. was a new Decade Capital Management position in Q3 2015.
  • Genomic Health, Inc. made up 1.91% of Decade Capital Management's portfolio in Q3 2015, its #17 holding.
  • 117 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2015.

Based on Decade Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.